{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T15:26:40Z","timestamp":1773674800526,"version":"3.50.1"},"reference-count":37,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2016,6,9]],"date-time":"2016-06-09T00:00:00Z","timestamp":1465430400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0156990","type":"journal-article","created":{"date-parts":[[2016,6,9]],"date-time":"2016-06-09T19:18:24Z","timestamp":1465499904000},"page":"e0156990","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":3,"title":["Tie2 Expressing Monocytes in the Spleen of Patients with Primary Myelofibrosis"],"prefix":"10.1371","volume":"11","author":[{"given":"Rita","family":"Campanelli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriela","family":"Fois","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Catarsi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina","family":"Poletto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Villani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benedetta Gaia","family":"Erba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luigi","family":"Maddaluno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Basilio","family":"Jemos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Salmoiraghi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Guglielmelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vittorio","family":"Abbonante","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian Andrea","family":"Di Buduo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Balduini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Iurlo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Barosi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vittorio","family":"Rosti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margherita","family":"Massa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"AGIMM Investigators","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2016,6,9]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1038\/leu.2014.3","article-title":"CALR vs JAK2 vs MPL-mutated or triple negative myelofibrosis: clinical, cytogenetic and molecular comparisons","volume":"28","author":"A Tefferi","year":"2014","journal-title":"Leukemia"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"3249","DOI":"10.1182\/blood.V98.12.3249","article-title":"Diagnostic and clinical relevance of the number of circulating CD34(+) cells in myelofibrosis with myeloid metaplasia","volume":"98","author":"G Barosi","year":"2001","journal-title":"Blood"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.1200\/JCO.1999.17.9.2954","article-title":"Myelofibrosis with myeloid metaplasia: diagnostic definition and prognostic classification for clinical studies and treatment guidelines","volume":"17","author":"G Barosi","year":"1999","journal-title":"J Clin Oncol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"3374","DOI":"10.1182\/blood.V96.10.3374","article-title":"Evaluation and clinical correlations of bone marrow angiogenesis in myelofibrosis with myeloid metaplasia","volume":"96","author":"RA Mesa","year":"2000","journal-title":"Blood"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/j.1365-2141.2004.04829.x","article-title":"Spleen neoangiogenesis in patients with myelofibrosis with myeloid metaplasia","volume":"124","author":"G Barosi","year":"2004","journal-title":"Br J Haematol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1080\/1042819021000040008","article-title":"Thalidomide in myelofibrosis with myeloid metaplasia: a pooled-analysis of individual patient data from five studies","volume":"43","author":"G Barosi","year":"2002","journal-title":"Leuk Lymphoma"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1182\/blood-2002-09-2928","article-title":"A phase 2 trial of combination low-dose thalidomide and prednisone for the treatment of myelofibrosis with myeloid metaplasia","volume":"101","author":"RA Mesa","year":"2003","journal-title":"Blood"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1038\/sj.leu.2402596","article-title":"Clinical efficacy and antiangiogenic activity of thalidomide in myelofibrosis with myeloid metaplasia. A pilot study","volume":"16","author":"PP Piccaluga","year":"2002","journal-title":"Leukemia"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"5688","DOI":"10.1200\/JCO.2005.09.021","article-title":"Circulating CD34+, CD133+, and vascular endothelial growth factor receptor 2-positive endothelial progenitor cells in myelofibrosis with myeloid metaplasia","volume":"23","author":"M Massa","year":"2005","journal-title":"J Clin Onc"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"e15277","DOI":"10.1371\/journal.pone.0015277","article-title":"High frequency of endothelial colony forming cells marks a non-active myeloproliferative neoplasm with high risk of splanchnic vein thrombosis","volume":"5","author":"V Rosti","year":"2010","journal-title":"PLoS One"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ccr.2005.08.002","article-title":"Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors","volume":"8","author":"M De Palma","year":"2005","journal-title":"Cancer cell"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.it.2007.09.004","article-title":"Tie2-expressing monocytes: regulation of tumor angiogenesis and therapeutic implications","volume":"28","author":"M De Palma","year":"2007","journal-title":"Trends Immunol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"5276","DOI":"10.1182\/blood-2006-10-053504","article-title":"Identification of proangiogenic TIE2-expressing monocytes (TEMs) in human peripheral blood and cancer","volume":"109","author":"MA Venneri","year":"2007","journal-title":"Blood"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.1182\/blood-2011-01-326827","article-title":"SuperSAGE evidence for CD14++CD16+ monocytes as a third monocyte subset","volume":"118","author":"AM Zawada","year":"2011","journal-title":"Blood"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.exphem.2013.12.002","article-title":"CD14 (bright)CD16(low) intermediate monocytes expressing Tie2 are increased in the peripheral blood of patients with primary myelofibrosis","volume":"42","author":"R Campanelli","year":"2014","journal-title":"Exp Hematol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1182\/blood-2007-04-083501","article-title":"Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycytemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panel","volume":"110","author":"A Tefferi","year":"2007","journal-title":"Blood"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1182\/blood-2009-09-245837","article-title":"A dynamic prognostic model to predict survival in primary myelofibrosis: a study by IWG-MRT (International Working Group for Myeloproliferative Neoplasms Research and Treatment)","volume":"115","author":"F Passamonti","year":"2010","journal-title":"Blood"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1136\/gut.44.5.754","article-title":"Thrombopoietin concentrations are low in patients with cirrhosis and thrombocytopenia and are restored after orthotopic liver transplantation","volume":"44","author":"J Goulis","year":"1999","journal-title":"Gut"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1182\/blood.V88.3.1013.1013","article-title":"Prognostic factors in agnogenic myeloid metaplasia: a report on 195 cases with a new scoring system","volume":"88","author":"B Dupriez","year":"1996","journal-title":"Blood"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1182\/blood-2010-06-288795","article-title":"Megakaryocyte-matrix interaction within bone marrow: new roles for fibronectin and factor XIII-A","volume":"117","author":"A Malara","year":"2011","journal-title":"Blood"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"5270","DOI":"10.1158\/0008-5472.CAN-10-0012","article-title":"Angiopoietin-2 regulates gene expression in TIE2-expressing monocytes and augments their inherent proangiogenic functions","volume":"70","author":"SB Coffelt","year":"2010","journal-title":"Cancer Res"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1002\/emmm.201302752","article-title":"Tie2-expressing monocytes\/macrophages regulate revascularization of the ischemic limb","volume":"5","author":"AS Patel","year":"2013","journal-title":"EMBO Mol Med"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1002\/hep.25965","article-title":"TIE2-expressing monocytes as a diagnostic marker for hepatocellular carcinoma correlates with angiogenesis","volume":"57","author":"T Matsubara","year":"2013","journal-title":"Hepatology"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3109\/07357907.2011.636114","article-title":"Analysis of Tie2-expressing monocytes (TEM) in patients with colorectal cancer","volume":"30","author":"V Goede","year":"2012","journal-title":"Cancer Invest"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"5150","DOI":"10.4049\/jimmunol.1402409","article-title":"CD14++CD16+ Monocytes Are Enriched by Glucocorticoid Treatment and Are Functionally Attenuated in Driving Effector T Cell Responses","volume":"194","author":"B Liu","year":"2015","journal-title":"J Immunol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1046\/j.1365-2230.2002.01146.x","article-title":"Traditional therapies: glucocorticoids, azathioprine, methotrexate,hydroxyurea","volume":"27","author":"G Belgi","year":"2002","journal-title":"Clin Exp Dermatol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1182\/blood-2009-01-200931","article-title":"A distinguishing gene signature shared by tumor-infitrating Tie2-expressing monocytes, blood \u201cresident\u201d monocytes, and embryonic macrophages suggests common functions and developmental relationships","volume":"114","author":"F Pucci","year":"2009","journal-title":"Blood"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1161\/ATVBAHA.111.243477","article-title":"Interleukin-1 assembles a proangiogenic signaling module consisting of caveolin-1, tumor necrosis factor receptor-associated factor 6, p38-mitogen-activated protein kinase (MAPK), and MAPK-activated protein kinase 2 in endothelial cells","volume":"32","author":"J Jagielska","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1002\/art.38263","article-title":"Thymidine phosphorylase regulates the expression of CXCL10 in rheumatoid arthritis fibroblast-like synoviocytes","volume":"66","author":"Y Toyoda","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"ref30","first-page":"158","article-title":"Thymidine phosphorylase (platelet-derived endothelial-cell growth factor) in cancer biology and treatment","volume":"6","author":"M Toi","year":"2005"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1002\/med.20159","article-title":"The dual role of thymidine phosphorilase in cancer development and chemotherapy","volume":"29","author":"A Bronckaers","year":"2009","journal-title":"Med Res Rev"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1582-4934.2007.00039.x","article-title":"Mammalian Heparanase: what is the message?","volume":"11","author":"V Vreys","year":"2007","journal-title":"J Cell Mol Med"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/NEN.0000000000000175","article-title":"TIMP-1 overexpression in lung carcinoma enhances tumor kinetics and angiogenesis in brain metastasis","volume":"74","author":"V Rojiani Mumtaz","year":"2015","journal-title":"J Neuropathol Exp Neurol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1161\/CIRCRESAHA.110.223750","article-title":"The role of wnt signaling in physiological and pathological angiogenesis","volume":"107","author":"E Dejana","year":"2010","journal-title":"Circ. Res"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1160\/TH12-06-0395","article-title":"CXCR4 positive and angiogenic monocytes in myocardial infarction","volume":"109","author":"E Shantsila","year":"2013","journal-title":"Thromb Haemost"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"e22148","DOI":"10.1371\/journal.pone.0022148","article-title":"JAK2 V617F-dependent upregulation of PU.1 expression in the peripheral blood of myeloproliferative neoplasm patients","author":"T Irino","year":"2011","journal-title":"PLoS ONE"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1101\/gad.242685.114","article-title":"The active enhancer network operated by liganded RXR supports angiogenic activity in macrophages","volume":"28","author":"B Daniel","year":"2014","journal-title":"Genes Dev"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0156990","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,22]],"date-time":"2020-09-22T00:01:17Z","timestamp":1600732877000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0156990"}},"subtitle":[],"editor":[{"given":"Francesco","family":"Bertolini","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2016,6,9]]},"references-count":37,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2016,6,9]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0156990","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,9]]}}}